Vaccinations and Allergy Risk: What the Data Shows

The concern that vaccines "cause allergies" has long been disproved by large cohort studies and systematic reviews. For most vaccines, no association has been found with the subsequent development of atopic dermatitis, asthma, allergic rhinitis, or food allergies. In some analyses, measles vaccination and tuberculosis vaccination have even shown associations with a lower incidence of eczema, but these signals are interpreted with caution. [1]

Actual allergic reactions to vaccination are rare and are almost always associated not with the development of a future allergy, but with immediate hypersensitivity to a vaccine component. Most often, these reactions involve gelatin, trace amounts of certain antibiotics, yeast proteins, latex in packaging elements, and polysorbate or polyethylene glycol in certain preparations. [2]

A key safety indicator, anaphylaxis after vaccination, is extremely rare. For traditional vaccines, its incidence is estimated at approximately 1 case per 1,000,000 doses administered. For messenger ribonucleic acid-based vaccines, early estimates were higher, but subsequent data have shown comparable rates. [3]

It's important to distinguish between two different questions: whether a vaccine can trigger an immediate allergic reaction in a specific individual on the day of vaccination, and whether vaccinations generally increase the risk of future allergic diseases in the general population. The answer to the first question is very rare and predictable due to known components. The answer to the second question is that there is no convincing evidence of an increased risk. [4]

What is a vaccine allergy and how is it different from normal reactions?

Immediate allergic reactions develop within the first few hours after vaccination. They may include hives, facial swelling, wheezing, a drop in blood pressure, or loss of consciousness. If anaphylaxis is suspected, immediate administration of epinephrine and observation are required. Having an emergency kit and 15-30 minutes of post-vaccination observation is standard practice. [5]

Frequent pain at the injection site, redness, mild fever, lethargy, and headache in the first 1-3 days are expected post-vaccination reactions, not allergies. They do not contraindicate subsequent doses. Mistakenly equating such reactions with allergies leads to unnecessary vaccination refusals and loss of protection. [6]

Late local skin nodules following vaccines containing aluminum adjuvant are a separate issue. This is not a systemic allergy, but a localized immune system reaction. Contact sensitization to aluminum is possible, but rare and usually limited to local manifestations. No association has been found between such reactions and an increased risk of atopy. [7]

Finally, "egg intolerance" is often mistakenly attributed to the measles, mumps, and rubella vaccines. These vaccines are safe for people with egg allergies because the viruses are grown in cell cultures rather than in eggs. If an allergic reaction is suspected, gelatin, not egg white, is more often the culprit. [8]

Table 1. Reactions to vaccinations: what is considered an allergy

Type of reaction	When does it arise?	What does this mean?	What to do
Anaphylaxis	The first minutes or hours	Immediate allergy	Adrenaline, emergency care, reporting to the pharmacovigilance system
Hives without a threat to breathing	The first hours	Mild allergy	Observation, symptomatic therapy, decision on further doses individually
Pain, swelling, fever	In the first 1-3 days	Expected post-vaccination reaction	Symptomatic remedies as needed
Late indurated nodule in aluminum-containing vaccines	Weeks	Local reaction	Observation, usually without treatment

Source for table: summarized from guidelines for the prevention and management of post-vaccination reactions. [9]

The Link Between Vaccines and Future Allergies: What Research Shows

Modern systematic reviews combining randomized and cohort studies have not found that routine childhood vaccinations increase the risk of allergic rhinitis, eczema, asthma, or food allergy. Measles vaccination has been associated with a lower incidence of eczema and asthma, but these are observational findings and should be interpreted with caution. [10]

Large studies on early sensitization have also found no link between early vaccinations and subsequent allergic sensitization. This is important in debunking the thesis that "early vaccinations overload the immune system" and "bias it toward allergies." [11]

Some studies in previous years found statistical associations between certain routine vaccinations and asthma symptoms. These analyses relied on self-reporting, had serious methodological limitations, and did not prove causality. Today, they are considered hypothesis-generating and do not change clinical recommendations. [12]

The idea that aluminum adjuvant "causes allergy" has been tested in large population studies. At the national level, no increased risk of atopic, allergic, autoimmune, or neurodevelopmental conditions was found with greater early exposure to aluminum in vaccines. This is consistent with long-term experience with the use of aluminum in allergen immunotherapy. [13]

Table 2. Summary of allergy risk after vaccination

Exodus	Connection with vaccination	Quality of evidence
Atopic dermatitis	It does not increase	Systematic reviews and cohort studies
Bronchial asthma	It does not increase	Systematic reviews and cohort studies
Allergic rhinitis	It does not increase	Cohort studies
Food allergy	It does not increase	Cohort studies
General risk of allergic diseases	It does not increase	Systematic reviews

The summary is based on systematic reviews and large cohort studies. [14]

Which components are most often responsible for allergic reactions?

Gelatin is one of the most common causes of immediate allergy to a number of live and inactivated vaccines. If anaphylaxis to gelatin is confirmed, alternative medications are considered or vaccination is administered under emergency preparedness conditions. [15]

Yeast proteins are present in some vaccines, such as hepatitis B. If anaphylaxis to yeast is documented, consultation with a specialist and individual selection of the vaccine are necessary. A non-specific "allergy to yeast baked goods" is not the same as anaphylaxis to yeast proteins in vaccines. [16]

Trace doses of antibiotics, neomycin, and latex in packaging elements can also trigger reactions in a very small percentage of people. In cases of anaphylaxis to latex, latex-free forms are chosen. Contact dermatitis to latex without anaphylaxis is not considered a contraindication. [17]

Polysorbates and polyethylene glycol have gained attention in the era of messenger ribonucleic acid-based vaccines. Severe allergy to polyethylene glycol is extremely rare, but it can increase the risk of an immediate reaction to certain drugs. This requires preliminary allergy evaluation and vaccination planning in an emergency preparedness setting. [18]

Table 3. Vaccine components and potential cross-risks

Component	Where it is found	Who should be attentive?	Comment
Gelatin	Some live and combination vaccines	For anaphylaxis to gelatin	A gelatin-free alternative is possible.
Yeast proteins	Vaccines against hepatitis B and others.	For anaphylaxis to yeast	Individual selection
Neomycin and other antibiotics in trace doses	A number of vaccines	In case of anaphylaxis to a specific antibiotic	Expert assessment
Latex in packaging	Vial stoppers, syringe plungers	For anaphylaxis to latex	Choose latex-free molds
Polysorbates and polyethylene glycol	Individual modern drugs	In case of confirmed allergy to these substances	Vaccination under supervision

Source for table: summarized from guidelines on vaccine formulations and best practices.[19]

Egg allergy and vaccination: modern rules

The combined measles, mumps, and rubella vaccine is safe for children and adults with egg allergies. In this vaccine, the viruses are grown in cell cultures rather than in the white or yolk, so an egg allergy does not increase the risk of a reaction. In rare cases, the reaction is due to gelatin rather than the egg. [20]

Seasonal inactivated influenza vaccines are approved for people with any degree of egg allergy. Most patients do not require additional test doses, special serums, or observation beyond the standard 15-30 minutes. If severe anaphylactic reactions have occurred in the past, the decision is made on an individual basis, but the general principle remains the same: vaccinate. [21]

In practice, the choice of a specific brand sometimes takes into account the composition of stabilizers. For example, for communities avoiding pork products, it is possible to choose measles, mumps, and rubella vaccines without porcine gelatin. The clinical value of this combination is to reduce the risk specifically associated with gelatin. [22]

The conclusion is simple: egg allergy alone is not a reason to delay vaccination against measles, mumps, and rubella, nor is it a reason to refuse seasonal influenza vaccination. This is confirmed in modern clinical documents and reports from professional societies. [23]

Messenger ribonucleic acid vaccines and immediate reactions

At the start of the campaigns, reports of immediate reactions raised alarm, but subsequent assessments showed that the incidence of anaphylaxis with these vaccines remains extremely low and comparable to traditional vaccines. Across registries and countries, the figures ranged from approximately 2 to 11 cases per 1,000,000 doses, which is in any case very rare. [24]

Polyethylene glycol has been implicated as a possible causative factor in a small number of patients. This substance has been found in some medications and may cause reactions in predisposed individuals. However, confirmed polyethylene glycol allergy itself is rare and requires specialized testing and management. [25]

Even in people who experienced an immediate reaction after the first dose, the risk of a severe reaction to a repeat dose was low when vaccination was administered under the supervision of an allergist and with a prepared plan. This is confirmed by meta-analyses and registry data. [26]

Clinical practice includes a pre-vaccination interview, emergency preparedness, and standard monitoring. In cases of documented anaphylaxis to a vaccine component, alternative platforms and formulations are used. In the absence of such a history, the usual guidelines apply, and refusing vaccination "just in case" deprives a person of protection against severe infections. [27]

Table 4. Estimated incidence of anaphylaxis by vaccine type

Type of vaccines	Estimated range of anaphylaxis incidence per 1,000,000 doses
Traditional vaccines in general	About 1-2
Messenger ribonucleic acid-based vaccines	Approximately 2-11 in different registers and observation periods

Summarized from tracking data and publications from the start of programs and subsequent analyses. [28]

A practical guide to safely vaccinating people with allergies

The first step is to determine whether the individual has had a severe immediate reaction to a previous dose or to a specific component. This is the only universal contraindication for this drug. If such a history is present, an alternative vaccine without the offending component is selected and administered under emergency preparedness conditions. [29]

The second step is to distinguish a true allergy from expected reactions. Arm pain, short-term fever, and fatigue are not allergies and do not require canceling subsequent doses. The myth of "cumulative sensitization from each vaccination" is not supported by clinical observations. [30]

The third step is to properly manage people with egg allergies. The combined measles, mumps, and rubella vaccine is administered routinely. Inactivated influenza vaccines are used based on age and condition. Most patients do not require additional measures beyond standard monitoring. [31]

The fourth step is preparing the room: adrenaline is readily available, the team is trained to recognize anaphylaxis and take appropriate action, and observation is required for 15-30 minutes after the injection. This organization minimizes risks and is consistent with best practices. [32]

Table 5. Before vaccination for a person with allergies: a short checklist

Question	Yes	No	Action
There was anaphylaxis to the dose or component			Choose an alternative drug and vaccinate under supervision
Egg allergy			Administer the measles, mumps, rubella vaccine and the influenza vaccine as usual
There are concerns about "gelatin, yeast, latex"			Check the composition and select an alternative if necessary.
The emergency kit is ready.			Standard observation 15-30 minutes

Source for table: summarized from best practice guidelines for immunization.[33]

Myths and facts

Myth: "Vaccinations cause atopy in children." Fact: Systematic reviews have found no increased risk of allergic diseases in vaccinated children. Furthermore, measles vaccination has been associated with a lower incidence of certain allergic outcomes. These are observational data, but they clearly refute the idea of an "increased risk." [34]

Myth: "Aluminum in vaccines causes allergic diseases." Fact: At the national level, a link between greater early exposure to aluminum and an increased risk of allergies, autoimmunity, or developmental disorders has not been confirmed. Local nodules after injections with aluminum adjuvants are possible, but this is not a generalized allergy. [35]

Myth: "An egg allergy prohibits the MMR and flu vaccines." Fact: Both vaccines are approved for people with egg allergies. For the combined MMR vaccine, the risk is primarily related to the gelatin, not the egg. [36]

Myth: "After a reaction to the first dose of messenger ribonucleic acid vaccine, a second dose is dangerous." Fact: With the involvement of an allergist and planned follow-up, the risk of a severe immediate reaction to a second dose is low, as confirmed by meta-analyses of cases. [37]

Table 6. Myths and facts about allergies and vaccinations

Myth	Fact
Vaccinations "cause allergies"	No, the risk of allergic diseases does not increase.
Aluminum is "allergenic"	There is no convincing evidence of an increase in atopy at the population level.
Egg allergy interferes with vaccination	Vaccination is permitted and is carried out in the usual manner.
A reaction to the first dose precludes a second.	With the help of a specialist, second doses are usually safe.

Sources of myths and facts - clinical guidelines and systematic reviews in total. [38]

What to do if a reaction does occur

If generalized urticaria, wheezing, facial swelling, a drop in blood pressure, or loss of consciousness occur within hours after the injection, anaphylaxis should be considered. The first line of treatment is immediate intramuscular injection of epinephrine. Other therapy is supportive and does not replace epinephrine. [39]

After the reaction subsides, the person is observed, the case is documented, and reported to the pharmacovigilance system. Further vaccination is discussed with an allergist: the likely causative component is identified, an alternative vaccine without this component is selected, and the conditions for subsequent doses are planned. [40]

For messenger ribonucleic acid-based vaccines, if polyethyleneglycol is suspected, a history of reactions to formulations containing this substance is assessed and, if necessary, specialized testing is performed. An alternative platform is then selected or vaccination is administered under observation with emergency preparedness. [41]

For individuals who have experienced mild, isolated local reactions or short-term fever, repeat doses are usually indicated as usual. These events are not considered allergies and do not increase the risk of a severe reaction to a subsequent dose. [42]

Table 7. Tactics after immediate response

Scenario	First action	Further
Signs of anaphylaxis	Adrenaline, calling emergency services	Monitoring, reporting to pharmacovigilance
Mild hives without a threat to breathing	Observation, symptomatic treatment	The decision on the next doses should be made in consultation with an allergist.
Isolated local reaction	Symptomatic relief	Vaccination according to schedule
Suspected allergy to a component	Allergist consultation	Selection of an alternative vaccine

Based on best practices for the prevention and management of post-vaccination reactions. [43]